PositiveID gets FDA clearance for iglucose technology

11/16/2011 | Health Data Management

The FDA has given PositiveID Corp. 510(k) clearance for its iglucose technology designed for patients with diabetes. The device enables patients to transmit blood glucose readings from a data-cable glucometer to a Web portal, where they can transmit information to family members and health care providers.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ